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Increasing evidence focuses on acetaldehyde (ACD) as the mediator of the rewarding
and motivational properties of ethanol. Indeed, ACD stimulates dopamine release in
the nucleus accumbens and it is self-administered under different conditions. Besides
the dopaminergic transmission, the endocannabinoid system has been reported to
play an important role in ethanol central effects, modulating primary alcohol rewarding
effect, drug-seeking, and relapse behavior. Drug motivational properties are highlighted
in operant paradigms which include response-contingent punishment, a behavioral
equivalent of compulsive drug use despite adverse consequences. The aim of this
study was thus to characterize ACD motivational and rewarding properties employing
an operant-conflict paradigm in which rats, trained to lever press in order to get ACD
solution (0.9%), undergo extinction, reinstatement and conflict sessions, according to
a modified Geller–Seifter procedure. Furthermore, the role played by CB1 receptor
system in modulating ACD-induced effects were investigated through the administration
of CB1 receptor antagonist, AM281 (1mg/kg, i.p.) during the extinction-, relapse-, and
conflict-experiments. Our results indicate that ACD is able to induce and maintain an
operant behavior, a high number of responses during extinction, an increase in the lever
presses during the reinstatement phase, and a higher emission of punished responses
during the conflict experiments, when compared to controls. The administration of AM281
is able to decrease ACD-seeking behavior during extinction, the number of lever presses
during reinstatement and to strongly decrease the punished responses for ACD. Our
data strengthen the idea that ACD may be responsible for the central effects of ethanol,
and pinpoint at the CB1 system as one of the neural substrates underlying its addictive
properties.
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INTRODUCTION
Evidence obtained in preclinical studies suggests that
Acetaldehyde (ACD), the first metabolite of ethanol, is bio-
logically active and may play a pivotal role in the rewarding,
motivational and addictive properties of alcohol, as recently
reviewed by Correa et al. (2012) and Deehan et al. (2013a).
ACD is obtained from ethanol oxidative metabolism, which
occurs by peripheral alcohol dehydrogenase, and by central cata-
lase and CYP2E1 (Zimatkin et al., 1998; Arizzi-LaFrance et al.,
2006; Zakhari, 2006; Jamal et al., 2007). High blood levels of ACD
enter the brain, likely overwhelming the aldehyde dehydrogenase
present in the blood-brain barrier (Quertemont et al., 2005).
ACD is able to affect dopamine neurotransmission, increasing
neuronal firing in the ventral tegmental area (VTA), thus stimu-
lating DA release in the nucleus accumbens (NAcc) shell (Melis
et al., 2007; Deehan et al., 2013b). Recent reports show that the
intra-VTA administration of a lentiviral vector, able to inhibit
catalase synthesis, and hence central ACD production, nearly
abolishes voluntary ethanol intake, as well as decreases ethanol-
induced DA release in the NAcc shell (Karahanian et al., 2011),
further supporting the compelling theory that ethanol may be
acting as a prodrug. Behavioral studies confirm that ACD admin-
istration is able to induce conditioned place preference (Smith
et al., 1984; Peana et al., 2008); furthermore rats readily self-
administer ACD solution in operant conditions through several
routes: centrally (Amit et al., 1977; Brown et al., 1979; Rodd et al.,
2005), and peripherally (Myers et al., 1982; Peana et al., 2010;
Cacace et al., 2012).
Besides the dopaminergic transmission, the brain endo-
cannabinoid (EC) system plays an important role in value-
attribution processing and in the modulation of reward-seeking
behavior for different drugs of abuse (Serrano and Parsons, 2011),
in view of its role as fine modulator of incoming inputs within the
VTA (Melis et al., 2012).
In particular, CB1 receptor manipulation is reported to affect
ethanol-related behavior, and in fact CB1 antagonism decreases
both voluntary ethanol intake and relapse to ethanol in several
experimental models (Arnone et al., 1997; Colombo et al., 1998;
Gallate and McGregor, 1999; Cippitelli et al., 2005; Economidou
et al., 2006; Femenía et al., 2010; De Bruin et al., 2011; Getachew
et al., 2011), suggesting that CB1 receptor blockade reduces the
rewarding value of ethanol. In turn, chronic administration of
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ethanol is associated with increased concentrations of endo-
cannabinoids, in accordance with a reduction in the activity of
their removal mechanisms, and in CB1 receptor expression, thus
affecting the system as a whole (Basavarajappa et al., 1998, 2000,
2003; Vinod et al., 2006).
Given these premises, it is worth focusing on CB1 receptor
involvement in ACD self-administration, employing an operant
conditioning paradigm which may reliably model the distinct
phases of the addiction cycle. Indeed, punishment resistance,
which represents the behavioral equivalent of compulsive drug
use despite negative consequences (Deroche-Gamonet et al.,
2004), is considered as a mandatory component in mirroring
the addictive phenotype, besides drug taking, drug seeking and
relapse (Marchant et al., 2013). Hence, by the assessment of the
capacity of orally self-administered ACD to induced andmaintain
an operant behavior after forced abstinence, and in the presence
of an aversive stimulus, according to a programmed schedule of
responding (Cannizzaro et al., 2011; Cacace et al., 2012), the eval-
uation of the influence of CB1 receptor blockade by AM281 was
carried out on ACD-seeking and relapse, and on compulsive-like
behavior.
MATERIALS AND METHODS
ANIMALS
Adult male Wistar rats (Harlan, Udine, Italy) weighing 250
to 300 g, were housed two per cage and maintained on a
12-h light/dark cycle, under controlled environmental condi-
tions (temperature 22 ± 2◦C; humidity 55 ± 10%) with food and
water available ad-libitum. During operant behavior experiments
they were water-restricted and allowed to drink only 1 h/day at the
end of the experimental sessions. Water intake was recorded. All
subjects were experimentally naive and randomly assigned to the
following groups (n = 16): ACD-drinking rats (ACD) which self-
administered a solution of ACD (0.9% v/v) and water-drinking
rats (CTR) which self-administered water. All experiments were
in accordance with the Committee for Use of Experimental
Animals of the University of Palermo, the Italian legislation D.L.
116/1992 and the European Union Council Directive 2010/63,
dealing with research on experimental animals.
DRUGS
ACD 99.98% (Sigma-Aldrich, Milan, Italy) was diluted in tap
water, in order to achieve a final concentration of 0.9% v/v
(0.450ml ACD in 50ml of water). ACD solution was daily pre-
pared, sealed with Parafilm (American Can Company), stored at
4◦C during experiments, aiming at avoiding concentration loss
(Cacace et al., 2012).
The CB1 selective cannabinoid antagonist AM281 (Sigma-
Aldrich, Milan, Italy) was dissolved in a vehicle of Tween 80
(3%) in saline solution (0.9% NaCl), and administered intraperi-
toneally (1mg/kg).
APPARATUS
The experimental sessions were carried out in a custom-built
operant-conditioning chamber (30 × 28 × 37 cm), included in
a dim-illuminated, ventilated, sound-attenuating cubicle. The
chamber was equipped with one active lever and a cup that
collected liquid from a corked reservoir, aiming at ACD solution
preservation from evaporation, with a solenoid-actuated delivery
system. It assured the delivery of 0.05ml of solution for each lever
pressing. Moreover, a foot-shock generator was able to deliver a
constant-current, intermittent, inescapable, foot-shock (0.2mA)
to the chamber grid floor. A light-cue above the lever turned on
during the punished period, allowing the animals to be aware
of the aversive stimulus. Animal performance was recorded on a
counter connected to the chamber. The devices were thoroughly
cleaned before the introduction of each animal to ensure that
the particular rat’s behavior was not affected by the detection of
another rat’s scent.
OPERANT SELF-ADMINISTRATION PROCEDURE
The lever pressing procedure was scheduled into four differ-
ent periods: Training—rewarded responses under a continuous
schedule of reinforcement; Extinction—non rewarded responses;
Relapse—reinstatement of the reinforced operant behavior fol-
lowing 1 week-deprivation; Conflict—rewarded responses cycli-
cally associated with a 0.2mA footshock.
Shaping and training
Animals underwent water deprivation for 23 h and then they were
shaped to lever press in order to obtain water on a continu-
ous reinforcement schedule (fixed ratio 1), until they achieved a
steady performance. Afterwards, during the Training session rats
orally self-administered ACD solution or water, according to their
group, in the operant chamber, under a fixed ratio 1, along 21
days. For each operant response, the system delivered 0.05ml of
water or 0.90% v/v ACD solution. The number of lever presses
was automatically recorded. Animals were tested each day at the
same time (9:00 to 14:00), and each trial lasted 20min.
Extinction
Animals underwent an operant responding session during which
reward delivery was suspended. The number of lever presses at the
end of the 20min session was recorded for both ACD andControl
groups.
Deprivation
ACD self-administration was suspended for 7 days to achieve a
forced abstinence. Rats were left undisturbed in their home cages
and received water and food ad-libitum.
Relapse
After the deprivation period, rats were exposed again to lever
pressing in the operant chamber with a fixed ratio 1 response
schedule for 7 days. Responses for ACD or water were recorded
during the 20min-experimental sessions.
Conflict
This protocol represented a modification of the Geller–Seifter
paradigm, a procedure in which a positive reinforcement (water
or ACD solution) is earned by an operant response; however,
delivery of the positive reinforce is paired with an aversive stimu-
lus, as a footshock. In our study, animals underwent alternatively
unpunished and punished responses according to “3 minutes–
1 minute” schedule. The session started and ended with an
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unpunished interval. The punishment was signaled by a cue-light
triggered by the response. During the punished response inter-
val, lever presses were rewarded with the solution and coupled
with a mild footshock of 0.2mA. The number of unpunished and
punished responses was automatically recorded.
Treatment
CB1 antagonist AM281 was administered to ACD-group 30min
before the experimental sessions, during extinction (1 day),
relapse (7 days), and conflict (7 days). Control rats were adminis-
tered intraperitoneally with vehicle.
Statistical analysis
Operant-drinking behavior. A Two-Way analysis of variance
(ANOVA) was conducted on the number of lever presses dur-
ing the training, extinction-, relapse- and conflict-sessions, as
dependent variables, with “ACD self-administration” (treatment)
as between-subjects factor, and “days” as repeated measurement
factor. When necessary, simple main effects and post-hoc com-
parisons were calculated with Bonferroni post-test (α = 0.05).
Differences were considered statistically significant if p < 0.05.
Furthermore, to compare the effect of AM281 treatment on ACD-
seeking behavior during extinction, a 2-tailed Student’s t-test for
unpaired measures was employed.
RESULTS
OPERANT SELF-ADMINISTRATION
Training period
The results of a Two-Way ANOVA for repeated measures includ-
ing ACD treatment as the between-subjects factor and “Days”
as within-subjects factor showed a significant effect of time,
treatment, and their interaction on the number of responses emit-
ted, F(20, 600) = 19.52, p < 0.0001; F(1, 30) = 5.16, p < 0.0304;
F(20,600) = 26.81, p < 0.0001. Although during the training
period both groups showed a similar pattern of operant-drinking
behavior, post-hoc analysis revealed significant differences along
the paradigm (Figure 1). In particular, at the beginning, rats
exposed for the first time to ACD in the operant paradigm,
showed a lower number of lever presses, and consequently a
reduced liquid intake, reaching an amount of ACD consumed of
259 ± 68mg/kg In the second week of the paradigm, ACD rats’
drinking behavior increased, displaying higher number of lever
presses and greater liquid intake 3 days of 7, displaying an average
intake of 325 ± 21mg/kg. Values from the third week of training
were considered as reference measure of ACD baseline operant
behavior. In this week, ACD rats’ lever presses were increased
significantly with respect to controls, 6 days of 7 (t = 7.32, p <
0.001; t = 3.106, p < 0.05; t = 6.359, p < 0.001; t = 6.906, p <
0.001; t = 5.843, p < 0.001; t = 5.745, p < 0.001), for a mean
ACD intake of 355 ± 17mg/kg. When water intake was measured
during the free-drinking hour at the end of the experimental ses-
sions, no differences were observed between the two experimental
groups.
Extinction
Rats were tested on the operant condition paradigm to assess
drug seeking when reward delivery was suspended. The effects
of AM281 treatment on ACD seeking behavior in terms of lever
presses were analyzed by a two-tailed Student’ t-test for unpaired
measures. Our data indicated that ACD was able to induce a sig-
nificant increase in the number of lever presses (t = 5.152, df =
30, p < 0.001) compared to control rats. AM281 administration
induced a reduction in the number of lever presses (t = 4.196,
df = 30, p < 0.001) in ACD group (Figures 2A,B). AM281 was
ineffective on control rats’ operant behavior for water.
Relapse
Following 7 days of abstinence from ACD self-administration,
rats were tested again in the operant chamber to assess whether
deprivation could influence their drinking behavior. The results
of a Two-Way ANOVA for repeated measures including ACD
treatment as the between-subjects factor and “Days” as within-
subjects factor showed a significant effect of time, treatment, and
FIGURE 1 | Number of lever presses during the 21 days of training period. Each value represents the means ± S.D. of 16 rats. #p < 0.05; +p < 0.01;
∗p < 0.001 vs. control groups. ( ) CTR, ( ) ACD.
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their interaction on the number of responses emitted, F(6,180) =
14.21, p < 0.0001; F(1, 180) = 41.14, p < 0.001; F(6, 180) = 15.79,
p < 0.0001. Bonferroni post-hoc analysis showed that ACD group
displayed an increased number of lever presses on day 1, 2, 4,
6, and 7 (t = 8.008., p < 0.001; t = 4.173, p < 0.001; t = 6.574,
p < 0.001; t = 8.231, p < 0.001; t = 4.320, p < 0.001) when
compared to controls (Figure 3A), reaching an average intake of
409 ± 37mg/kg. Furthermore, when animals received the selec-
tive cannabinoid antagonist AM281, statistical analysis performed
by a Two-Way ANOVA for repeated measures, including AM281
treatment as the between-subjects factor and “Days” as within-
subjects factor, showed a significant effect of time, treatment, and
their interaction on the number of responses emitted, F(6, 180) =
4.61 p < 0.0002; F(1, 180) = 39.57, p < 0.001; F(6, 180) = 7.82,
p < 0.0001. Bonferroni post-hoc analysis showed that AM281
was able to induce a reduction in the number of lever presses
in all days of relapse (t = 4.763, p < 0.001; t = 6.836, p <
0.001; t = 3.028, p < 0.05; t = 4.522, p < 0.001; t = 3.944, p <
0.001; t = 7.936, p < 0.001; t = 5.448, p < 0.001) in ACD group
FIGURE 2 | Effects of ACD (A) and AM281 treatment (B) on the number
of lever presses during the extinction day. Each value represents the
means ± S.D. of 16 rats. ∗p < 0.001 vs. respective control groups.
(Figure 3B) leading to a decrease in the amount of ACD con-
sumed (266 ± 16mg/kg). No significant differences in the num-
ber of lever presses were recorded when AM281 was administered
to control rats.
Conflict
In this set of experiments, rats underwent a cyclic schedule of
unpunished and punished rewarded responses. Results of a Two-
Way ANOVA for repeated measures, including ACD treatment
as the between-subjects factor and “Days” as within-subjects fac-
tor on unpunished responses, showed a significant effect of time,
treatment, and their interaction on the number of responses emit-
ted, F(6, 180) = 3.80, p < 0.0014; F(1,180) = 74.32, p < 0.0001;
F(6,180) = 2.35, p < 0.0328. Bonferroni post-hoc analysis showed
that ACD group displayed an increase in the number of unpun-
ished lever presses on day 1, 2, 3, 4, 5, and 6 (t = 5.009, p < 0.001;
t = 5.417, p < 0.001; t = 3.064, p < 0.05; t = 4.686, p < 0.001;
t = 3.677, p < 0.01; t = 5.817, p < 0.001) when compared to
controls (Figure 4A), and greater amount of ACD consumed
(377 ± 31mg/kg). When the parameter “punished responses”
was analyzed, a Two-Way ANOVA for repeated measures includ-
ing ACD treatment as the between-subjects factor and “Days”
as within-subjects factor, showed a significant effect of time,
treatment, and their interaction on the number of responses emit-
ted, F(6, 180) = 16.62, p < 0.0001; F(1, 180) = 585.43, p < 0.0001;
F(6, 180) = 3.07, p < 0.0070. Bonferroni post-hoc analysis showed
that ACD group displayed an increase in the number of punished
lever presses along the conflict period (t = 7.584, p < 0.001; t =
5.583, p < 0.001; t = 6.162, p < 0.001; t = 6.847, p < 0.001; t =
8.980, p < 0.001; t = 9.085, p < 0.001; t = 10.56, p < 0.001)
when compared to controls (Figure 4B), reaching an average
amount of ACD ingested of 43 ± 23mg/kg.
When animals received AM281, statistical analysis by a Two-
Way ANOVA for repeated measures including AM281 treat-
ment as the between-subjects factor and “Days” as within-
subjects factor, showed a significant effect of time, treatment, and
their interaction on the number of unpunished responses emit-
ted, F(6, 180) = 32.43, p < 0.0001; F(1, 180) = 38.50, p < 0.0001;
FIGURE 3 | Effects of ACD (A) and AM281 treatment (B) on the number of lever presses during the relapse periods. Each value represents the means
± S.D. of 16 rats. #p < 0.05; ∗p < 0.001 vs. respective controls. ( ) CTR, ( ) ACD, ( ) (ACD-AM281).
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F(6, 180) = 5.09, p < 0.0001. Bonferroni post-hoc analysis showed
that AM281 was able to induce a decrease in the number of
unpunished lever presses in day 1, 2, 5 (t = 7.649, p < 0.001;
t = 4.146, p < 0.001; t = 4.229, p < 0.001) in ACD group com-
pared to respective controls (Figure 5A), and lower amount of
ACD consumed (259 ± 21mg/kg). When the parameter “pun-
ished responses” was analyzed after AM281 administration, the
results of a Two-Way ANOVA for repeated measures, includ-
ing ACD treatment as the between-subjects factor and “Days”
as within-subjects factor, showed a significant effect of time,
treatment, and their interaction on the number of responses emit-
ted, F(6, 180) = 5.21, p < 0.0001; F(1, 180) = 328.73, p < 0.0001;
F(6, 180) = 4.19, p < 0.0001. Bonferroni post-hoc analysis showed
that AM281 was able to induce a decrease in the number of
punished lever presses along the conflict period (t = 12.01, p <
0.001; t = 7.791, p < 0.001; t = 6.779, p < 0.001; t = 6.203, p <
0.001; t = 7.345, p < 0.001; t = 9.057, p < 0.001; t = 9.280, p <
0.001) (Figure 5B) compared to their respective controls, reach-
ing an average amount of ACD ingested of 12 ± 1mg/kg. No
significant difference in the number of unpunished and pun-
ished responses was recorded when AM281 was administered to
control rats.
DISCUSSION
The aim of the current study was to evaluate whether ACD could
induce and maintain a self-administration drinking behavior in
an operant-conditioning paradigm which consisted of training-,
extinction-, reinstatement and conflict phases (Cannizzaro et al.,
2011; Cacace et al., 2012), in order to demonstrate ACD rein-
forcing and motivational properties. Afterwards we pointed at
exploring the effect of AM281, a CB1 antagonist, on drug-seeking,
drug-taking and drug-induced compulsive-like behavior.
FIGURE 4 | Differences in the number of unpunished (A) and punished (B) responses during the conflict periods in ACD-and in water-drinking rats.
Each value represents the means ± S.D. of 16 rats. #p < 0.05; +p < 0.01; ∗p < 0.001 vs. control groups. ( ) CTR, ( ) ACD.
FIGURE 5 | Effects of the administration of AM281 on the number of unpunished (A) and punished (B) responses during the conflict periods in ACD
treated rats. Each value represents the means ± S.D. of sixteen rats. ∗p < 0.001 vs. control groups. ( ) ACD, ( ) (ACD-AM281).
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There is increasing interest in developing animal models that
more closely mimic addiction diagnostic criteria (DSM-IV-TR,
American Psychiatric Association, 2000) than classical reinstate-
ment models (Vanderschuren and Ahmed, 2012). Based on this
awareness, the experimental protocol implemented in the present
study aimed at evaluating the co-occurrence of various aspects
of the addictive phenotype, such as the increase in drug use over
time; difficulty in restricting drug intake or consuming more than
intended; perseveration in drug abuse despite its negative con-
sequences. Our data show that ACD exerted motivational and
reinforcing activity, since it was able to induce and maintain
an operant drinking behavior; it induced drug-seeking during
extinction, and a relapse behavior after 1-week forced abstinence;
remarkably, ACD rats displayed a higher emission of punished
responses with respect to controls, in a modified Geller–Seifter
conflict procedure, which may efficaciously model compulsive
drug taking despite negative consequences.
In detail, our results confirm data from a previous study
(Cacace et al., 2012), showing that rats readily acquire ACD
operant self-administration, according to a fixed ratio of rein-
forcement, during the training sessions. The number of lever
presses for ACD increased over the 3 weeks of training, signif-
icantly overcoming control group’s lever presses for water from
the second week. Moreover when animals were allowed to freely
access to water, no significant differences in water intake were
observed between the two groups, a finding that accounts for
ACD specific motivational effects.
Given that escalation of drug intake is a well-known phe-
nomenon in oral ethanol self-administration studies (Wise,
1973), our data clearly show that ACD shares this feature with
ethanol and suggest a direct role in the progressive loss of con-
trol over drinking behavior. Difficulty in abstaining from drug
use can be studied in animals by assessing drug seeking when
the drug is no longer available that is to say extinction paradigm
(Ahmed, 2012). Our results indicate that ACD induced a drug-
seeking behavior, since ACD group emitted a significantly higher
number of lever presses in the extinction experiment with respect
to controls. ACD-self administering rats persisted in respond-
ing in an attempt to earn the rewarding substance, due to the
motivational property of ACD; in fact water self-administering
rats showed an earlier extinction of responding, due to the lower
value of the reward. This finding allows us to speculate that
in ACD group the formation of specific ACD-related associa-
tions becomes overly salient, thus enhancing craving for ACD.
In the operant conditioning paradigm, reinstatement refers to
the rapid resumption of drug-reinforced operant response in
animals previously extinguished from drug self-administration
training (Marchant et al., 2013). This experimental modelmirrors
the relapse behavior observed in humans, the most troublesome
facet of addiction. ACD oral self-administration sustained a rein-
statement in animals. Indeed, ACD-rats, previously exposed to
extinction and 1-week forced abstinence, displayed a higher num-
ber of lever presses with respect to controls, during the relapse
phase. Furthermore, in the first relapse day, lever presses for ACD
were higher than in the last training day, suggesting that ACD
maintained acute reinforcing strength and motivation even after
extinction and deprivation (Martin-Fardon and Weiss, 2013). It
is well-known that repeated drug use leads enhances the salience
attributed to drugs and drug-associated contexts (Robinson and
Berridge, 2008), increasing their consumption following periods
of abstinence (Hölter et al., 1998; Rodd et al., 2003). Accordingly,
ACD-drinking rats showed a ready resumption of the operant
drinking behavior, and displayed a significant effect of depri-
vation, suggesting that ACD might be also involved in alcohol
deprivation effect during relapse (Spanagel and Hölter, 1999).
Drug self-administration in the presence of response-
contingent shock punishment highlights the motivational prop-
erties of substances and it reliably models compulsive drug use
despite adverse consequences (Deroche-Gamonet et al., 2004).
Moreover, increasing attention is paid to addiction models that
focus on punishment-resistance, as a core feature in captur-
ing the addictive phenotype (Vanderschuren and Ahmed, 2012).
Given these premises, we developed the operant-conflict pro-
cedure in order to assess whether ACD consumption itself was
resistant to aversive consequences associated to drug intake. In the
operant-conflict procedure, responses were alternatively paired to
a footshock, signaled by a light-cue. In the conflict paradigm rats
suffer from the “conflict” between the drive to drink and the fear
of the shock: this usually leads to a suppression of conditioned
responses for reinforcement. The aversive stimulus has a general
dissuasive effect in the operant behavior for water, as it strongly
decreases the number of lever presses in CTR group. Despite its
highly negative value, the contingent punishment less effectively
inhibited operant responding for ACD, and a higher number of
punished responses was observed, with respect to controls. It
seemed that ACD shares ethanol anti-conflict properties (Baldwin
et al., 1991), but since ACD-rats showed an increase both in pun-
ished and unpunished responses, it is reasonable to interpret our
data recalling ACD strong motivational properties, rather than an
anti-conflict effect. Indeed, ACD appears to be a 1000-fold more
potent reinforcement than ethanol in the posterior VTA (Rodd
et al., 2005). Besides, ACD involvement in recruiting the neuroen-
docrine stress system (Cannizzaro et al., 2010; Escrig et al., 2012)
may be crucial in the development of negative emotional states,
thus leading to the progressive loss of control in drinking behav-
ior and compulsive alcohol intake (Koob, 2013). A major finding
of the present study was the pharmacological probing of ACD
reinforcing and motivational properties, addressing the AM281
effect in the distinct addiction-related behaviors explored, namely
drug-seeking, relapse and punishment resistance. Recent preclin-
ical and clinical data indicate that CB1 receptor antagonists, such
as SR141716A (SR, Rimonabant), can reduce self-administration
and craving for several commonly addictive drugs (Colombo
et al., 1998; De Vries et al., 2001; Navarro et al., 2001; Cohen
et al., 2005; Rigotti et al., 2009). CB1 function is required for
ethanol-mediated activation of VTA DA neurons (Cheer et al.,
2007), supporting the hypothesis that ethanol rewarding prop-
erties are due in part to ECs release, which likely exerts reduction
of GABA inhibition onto VTA dopamine neurons (Lupica and
Riegel, 2005; Barrot et al., 2012). This effect is quite specific,
since the neuroanatomical loci of the SR-mediated reduction in
ethanol self-administration involve brain regions typically associ-
ated with addiction; indeed SR microinjections into VTA, medial
prefrontal cortex and NAcc reduce ethanol self-administration,
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whereas injections into the dorsal striatum do not affect the
number of responses for ethanol (Caillé et al., 2007; Hansson
et al., 2007; Malinen and Hyytiä, 2008). AM281 is structurally
related to SR, but displays higher affinity and specificity for CB1
receptor (Gatley et al., 1998), since it does not interact with
GPR55 and opioid receptors (Seely et al., 2012). Our results
show that AM281 administration was able to decrease ACD-
seeking, ACD-relapse after forced abstinence, and ACD-induced
resistance to punishment in highly predictive experimental pro-
cedures. Indeed, animals receiving the CB1 antagonist emitted
a lower number of responses for ACD with respect to vehi-
cle group during extinction. This evidence suggests that ACD
positive incentive properties underlie perseveration in lever press-
ing when reinforce delivery is suspended. No significant effect
was recorded in water-administering rats, ruling out an aspecific
action on operant responding. AM281 administration induced a
significant reduction in lever-pressing during the relapse session,
when compared to their respective controls. This finding further
suggests a role for CB1 receptor in ACD-induced as well as it has
been reported in alcohol-related addictive behavior (Serrano and
Parsons, 2011). Ultimately, AM281 administration in the con-
flict paradigm decreased the number of punished lever presses
for ACD, and a similar though less evident effect was observed
in unpunished ones. At this regard, an aspecific effect of the
CB1 antagonist on motor activity seems unlikely, since AM281
administration was able to affect unpunished responses for
ACD discontinuously, while the reduction of punished responses
occurred along the whole conflict period. This effect may be
related to a decrease in the incentive for lever-pressing due to the
pharmacological treatment. The clear influence of CB1 receptor
activity on ACD-induced punishment resistance further high-
lights the involvement of the reward-processing machinery as
the intrinsic mechanisms underlying ACD-related behavioral fea-
tures. As a matter of fact, these data provide evidence of ACD
incentive properties, whose contribution must be taken into
account in studying and treating ethanol-related behaviors. The
neural substrates underpinning rewarding properties of orally
self-administer ACD involve CB1 receptors, which are able to
indirectly modulate DA mesocorticolimbic pathway. Drugs able
to manipulate EC system might represent a useful therapeu-
tic strategy affecting both ethanol and its neuroactive metabo-
lite actions on crucial addiction-related behaviors, such as drug
seeking, relapse and drug abuse despite negative consequences.
This study aims at representing a step forward in elucidating
the complex framework of actors playing a role in maintain-
ing ethanol addiction; nevertheless further efforts are needed to
fully characterize the actual contribution of ACD to ethanol’s
effects.
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